Literature DB >> 28279678

Mitral valve morphology assessed by three-dimensional transthoracic echocardiography in healthy dogs and dogs with myxomatous mitral valve disease.

G Menciotti1, M Borgarelli2, M Aherne2, S Wesselowski2, J Häggström3, I Ljungvall3, S M Lahmers2, J A Abbott2.   

Abstract

OBJECTIVE: To assess differences in morphology of the mitral valve (MV) between healthy dogs and dogs affected by myxomatous mitral valve disease (MMVD) using real-time transthoracic three-dimensional echocardiography (RT3DE). ANIMALS: Thirty-four were normal dogs and 79 dogs were affected by MMVD.
METHODS: Real-time transthoracic three-dimensional echocardiography mitral datasets were digitally recorded and analyzed using dedicated software. The following variables were obtained and compared between healthy dogs and dogs with MMVD at different stages: antero-posterior annulus diameter, anterolateral-posteromedial annulus diameter, commissural diameter, annulus height, annulus circumference, annulus area, anterior leaflet length, anterior leaflet area, posterior leaflet length, posterior leaflet area, non-planar angle, annulus sphericity index, tenting height, tenting area, tenting volume, the ratio of annulus height and commissural diameter.
RESULTS: Dogs with MMVD had a more circular MV annulus compared to healthy dogs as demonstrated by an increased annulus sphericity index (p=0.0179). Affected dogs had a less saddle-shaped MV manifest as a decreased annulus height to commissural width ratio (p=0.0004). Tenting height (p<0.0001), area (p<0.0001), and volume (p<0.0001) were less in affected dogs.
CONCLUSIONS: Real-time transthoracic three-dimensional echocardiography analysis demonstrated that dogs affected by MMVD had a more circular and less saddle-shaped MV annulus, as well as reduced tenting height area and volume, compared to healthy dogs. Multiple variables differed between dogs at different stages of MMVD. Diagnostic and prognostic utility of these variables, and the significance of these changes in the pathogenesis and natural history of MMVD, require further attention.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Degeneration; Diagnostic imaging; Heart

Mesh:

Year:  2017        PMID: 28279678     DOI: 10.1016/j.jvc.2017.01.002

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  5 in total

1.  Comparison of the mitral valve morphologies of Cavalier King Charles Spaniels and dogs of other breeds using 3D transthoracic echocardiography.

Authors:  Giulio Menciotti; Michele Borgarelli; Michael Aherne; Paula Camacho; Jens Häggström; Ingrid Ljungvall; Sunshine M Lahmers; Jonathan A Abbott
Journal:  J Vet Intern Med       Date:  2018-09-20       Impact factor: 3.333

2.  ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.

Authors:  Bruce W Keene; Clarke E Atkins; John D Bonagura; Philip R Fox; Jens Häggström; Virginia Luis Fuentes; Mark A Oyama; John E Rush; Rebecca Stepien; Masami Uechi
Journal:  J Vet Intern Med       Date:  2019-04-11       Impact factor: 3.333

3.  Use of proposed systolic and myocardial performance indices derived from simultaneous ECG and PCG recordings to assess cardiac function in healthy Beagles.

Authors:  Karlo Romano B Gicana; Chirutchaya Pinidmontree; Kitchanan Kosalathip; Siraphop Sirirut; Siripen Komolvanich; Sariya Asawakarn; Walasinee Sakcamduang; Phornphop Naiyanetr; Kittipong Tachampa
Journal:  Vet World       Date:  2022-07-25

Review 4.  Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease.

Authors:  Giulio Menciotti; Michele Borgarelli
Journal:  Vet Sci       Date:  2017-09-26

5.  The genetic consequences of dog breed formation-Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels.

Authors:  Erik Axelsson; Ingrid Ljungvall; Priyasma Bhoumik; Laura Bas Conn; Eva Muren; Åsa Ohlsson; Lisbeth Høier Olsen; Karolina Engdahl; Ragnvi Hagman; Jeanette Hanson; Dmytro Kryvokhyzha; Mats Pettersson; Olivier Grenet; Jonathan Moggs; Alberto Del Rio-Espinola; Christian Epe; Bruce Taillon; Nilesh Tawari; Shrinivas Mane; Troy Hawkins; Åke Hedhammar; Philippe Gruet; Jens Häggström; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2021-09-02       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.